Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), ...

Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), ...

New research found that the medication spironolactone, often prescribed for hypertension (high blood pressure), may reduce the risk of heart failure in people recovering from a heart attack.

Both studies were presented at the American College of Rheumatology (ACR) annual meeting.

As someone who is now using colchicine routinely, these data have changed his opinion, he said. The previous data supporting the use of colchicine "were just so-so," he explained. "Now I have a good ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense and respond to danger. However, for people with risks for heart disease, ...

The trial was small and halted early, but investigators say the inflammatory hypothesis in TAVI is worth pursuing further.

found that both acute and long-term colchicine use did not reduce cardiovascular death, myocardial infarction, stroke, or ischemia-driven revascularization. Findings were reported today at TCT ...

Available generically, colchicine is derived from the autumn crocus plant used medicinally for thousands of years in Egypt. Last year, the FDA approved brand-name colchicine (Lodoco) as the first ...

Copyright 2024 The Associated Press. All Rights Reserved. Elon Musk speaks before Republican presidential nominee former President Donald Trump at a campaign rally at ...

WASHINGTON, DC—The routine use of colchicine, an anti-inflammatory agent with a challenging side-effect profile, fails to reduce the risk of major adverse cardiovascular events when used in patients ...

Both acute and long-term colchicine use to treat patients with acute myocardial infarction (MI) did not reduce cardiovascular death, myocardial infarction, stroke or ischemia-driven revascularization, ...